PAXMAN invitation to Capital Market Day

PAXMAN, the world leader in chemotherapy side effect management, is pleased to invite investors and other interested parties to a Capital Market Day on Wednesday, November 26, 2025.

During the day, representatives from the company will speak about the company’s core business of scalp cooling, reimbursement in the U. S., the merger with Dignitana, as well as its latest side effect management work related to chemotherapy-induced peripheral neuropathy (CIPN). CEO Richard Paxman OBE and Dr. Aishwarya Bandla, Regional R&D Manager at Paxman, who has led the development of a wearable limb cryocompression device to prevent CIPN, will be presenting at the event.

The event will be held at Carnegie’s premises in Stockholm, Sweden and a live webcast will be available for those who cannot attend in person.

Location: Regeringsgatan 56, 111 56 Stockholm.

Date & Time: 26 November 2025, 13:00-17:00, a small lunch will be served 12:15-13:00.

Registration for physical or online attendance to the Capital Market Day can be done via this link.

For inquiries regarding event-related questions, kindly send an email to anna.olsson@carnegie.se.

Datum 2025-10-09, kl 10:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!